Chlorhexidine Cleansing of the Umbilical Cord and Separation Time: A Cluster-Randomized Trial

Author:

Mullany Luke C.1,Shah Rasheduzzaman1,El Arifeen Shams2,Mannan Ishtiaq3,Winch Peter J.1,Hill Amber1,Darmstadt Gary L.4,Baqui Abdullah H.12

Affiliation:

1. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;

2. International Centre for Diarrheal Disease Research, Dhaka, Bangladesh;

3. Save the Children, Dhaka, Bangladesh; and

4. Family Health Division, Bill and Melinda Gates Foundation, Seattle, Washington

Abstract

OBJECTIVE: Cord cleansing with chlorhexidine reduces neonatal mortality. We aimed to quantify the impact of this intervention on cord separation time and the implications of such an increase on maternal and other caretaker’s acceptance of chlorhexidine in future scaled up programs. METHODS: Between June 2007 and September 2009, 29 760 newborns were randomly assigned within communities in Bangladesh to receive 1 of 3 cord regimens: dry and clean cord care (comparison), single-cleansing, or multiple-cleansing with 4.0% chlorhexidine. Workers recorded separation status during home visits. Mothers of 380 infants in randomly selected clusters reported age at separation and satisfaction with cord regimen. RESULTS: Compared with dry and clean care (mean 4.78 days), separation time was longer in the single (mean 6.90 days, difference = 2.10; 95% confidence interval: 1.85–2.35) and multiple (mean 7.49 days, difference = 2.69; 95% confidence interval: 2.44–2.95) cleansing groups. Increased separation time was not associated with omphalitis. Mothers in these groups more frequently reported “longer than usual” separation times and dissatisfaction with the separation time (11.1% and 17.6%, respectively) versus the comparison group (2.5%). Overall satisfaction with the received cord care regimen was high (96.2%). CONCLUSIONS: Topical chlorhexidine increased cord separation time by ∼50%. Caretakers are likely to detect this increase and might express dissatisfaction but still accept the intervention overall. When scaling up chlorhexidine cord cleansing, inclusion of appropriate messaging on expectation and nonrisks of increased cord separation time, in addition to the benefits of reduced infection and improved survival, might improve compliance.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Reference31 articles.

1. Topical applications of chlorhexidine to the umbilical cord for prevention of omphalitis and neonatal mortality in southern Nepal: a community-based, cluster-randomised trial.;Mullany;Lancet,2006

2. The effect of cord cleansing with chlorhexidine on neonatal mortality in rural Bangladesh: a community-based, cluster-randomised trial.;Arifeen;Lancet,2012

3. Topical application of chlorhexidine to neonatal umbilical cords for prevention of omphalitis and neonatal mortality in a rural district of Pakistan: a community-based, cluster-randomised trial.;Soofi;Lancet,2012

4. Boston University. Zambia Chlorhexidine Application Trial (ZamCAT). ClinicalTrials.gov. Bethesda, MD: National Library of Medicine; 2000. Available at: http://clinicaltrials.gov/ct2/show/NCT01241318 (NLM Identifier: NCT01241318). Accessed September 14, 2012

5. Johns Hopkins Bloomberg School of Public Health. Chlorhexidine Cordcare for Reduction in Neonatal Mortality and Omphalitis (CHX-Pemba). ClinicalTrials.gov. Bethesda, MD: National Library of Medicine; 2000. Available at: http://clinicaltrials.gov/ct2/show/NCT01528852 (NLM Identifier: NCT01528852). Accessed September 14, 2012

Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3